|
|
 |
|
Viewing report
|
|
|
|
Global Cancer Treatment Forecast to 2012
RNCOS E-Services Private Limited, Aug 2008, Pages: 85
1. Analyst View
2. The Global Burden of Cancer
2.1 Cancer - A Leading Cause of Death
2.2 Prevalence
2.3 Factors Inducing Cancer
3. Global Cancer Market
3.1 Market Size
3.2 Market Segmentation
3.3 Drug Pipelines
3.4 Key Players
3.5 Key Drugs
4. Current & Future Treatments
4.1 Chemotherapy
4.1.1 Introduction
4.1.2 Market Analysis
4.1.2.1 Plant Alkaloids
4.1.2.2 Alkylation Agents
4.1.2.3 Anti-metabolites
4.1.2.4 Platinum Compounds
4.1.2.5 Cytotoxic Antibiotics
4.1.2.6 Other Cytostatics
4.2 Antiangiogenics
4.2.1 Introduction
4.2.2 Market Analysis
4.3 Hormone Therapy
4.3.1 Introduction
4.3.2 Market Analysis
4.4 Monoclonal Antibodies
4.4.1 Introduction
4.4.2 Market Analysis
4.5 Vaccines
4.5.1 Introduction
4.5.2 Market Analysis
5. Key Markets
5.1 US
5.1.1 Prevalence
5.1.2 Market Analysis
5.2 Europe
5.2.1 Prevalence
5.2.2 Market Analysis
5.3 Japan
5.3.1 Prevalence
5.3.2 Market Analysis
5.4 India & China
5.4.1 Prevalence
5.4.2 Market Analysis
6. Opportunities
6.1 Drug Delivery & Packaging Market
6.2 Diagnostic Devices
6.3 Cancer Generics
6.4 Contract Research & Manufacturing
7. Roadblocks
7.1 High Clinical Failure Rates
7.2 Reimbursements
7.3 Affordability
7.4 Side Effects
Tables
Table 2-1: Global - New Cancer Cases* in Males by Type (in Number), 2007E
Table 2-2: Global - New Cancer Cases* in Females by Type (in Number), 2007E
Table 3-1: Global - Revenues from Major Therapy Areas (in Million US$), 2007 & 2012F
Table 3-2: Global - Growth of various Cancer Drugs (%), 2007-2012
Table 3-3: Global - Sales of Top Companies in Cancer Market* (in Million US$), 2007
Table 3-4: Global - Forecast for Sales of Top Companies in Cancer Market* (in Million US$), 2012
Table 3-5: Global - Sales* of Top Cancer Drugs (in Billion US$), 2002
Table 3-6: Global - Sales* of Top Cancer Drugs (in Billion US$), 2006
Table 3-7: Global - Forecast for Sales* of Top Cancer Drugs (in Billion US$), 2012
Table 5-1: US - New Cancer Cases* for Selected Cancer Sites (in Number), 2008F
Table 5-2: US - Key Players in the Cancer Market by Rank (2000 & 2005)
Table 5-3: Europe - New Cancer Cases in Top 5 Countries (in ‘000), 2006
Table 5-4: Japan - Leading Sites of Cancer Incidences in Males & Females (%), 2001
Figures
Figure 2-1: Global - Leading Causes of Death (%), 2005E
Figure 2-2: Global - New Cancer Cases* (in Million), 2002, 2007, 2012F & 2020F
Figure 2-3: Global - New Cancer Cases* in Males by Type (%), 2007E
Figure 2-4: Global - New Cancer Cases* in Females by Type (%), 2007E
Figure 2-5: Global - New Cancer Cases by Region (in Number), 2007E
Figure 2-6: Global - Leading Causes of Cancer (%)
Figure 3-1: Global - Cancer Market (in Billion US$), 2007-2012F
Figure 3-2: Global - Cancer Market by Drug Type (%), 2007
Figure 3-3: Global - Forecast for Cancer Market by Drug Type (%), 2012
Figure 3-4: Global - Drugs under Clinical Development by Therapy Area (%), 2007
Figure 3-5: Global - Cancer Drugs by Type in Phase-II Clinical Development Process (%), 2006
Figure 3-6: Global - Cancer Drugs by Type in Phase-III Clinical Development Process (%), 2006
Figure 3-7: Global - In-licensing Deals by Therapy Area (%), 2006
Figure 4-1: Global - Chemotherapy Market (in Million US$), 2007-2012F
Figure 4-2: Global - Plant Alkaloids Market (in Million US$), 2007-2012F
Figure 4-3: Global - Alkylation Agents Market (in Million US$), 2007-2012F
Figure 4-4: Global - Anti-metabolites Market (in Million US$), 2007-2012F
Figure 4-5: Global - Platinum Compounds Market (in Million US$), 2007-2012F
Figure 4-6: Global - Cytotoxic Antibiotics Market (in Million US$), 2007-2012F
Figure 4-7: Global - Other Cytostatics Market (in Million US$), 2007-2012F
Figure 4-8: Global - Antiangiogenics Market (in Million US$), 2007-2012F
Figure 4-9: Global - Hormone Therapy Market for Cancer Treatment (in Million US$) 2007-2012F
Figure 4-10: Global - Hormone Therapy Market Segmentation for Cancer Treatment (%), 2004 & 2014F
Figure 4-11: Global - Monoclonal Antibodies Market (in Million US$), 2007-2012F
Figure 4-12: Global - Cancer Vaccine Market (in Million US$), 2006, 2007E & 2012F
Figure 4-13: Global - Cancer Vaccine by Type in various Phases of Clinical Development (in Number), Aug 2005
Figure 5-1: US - New Cancer Cases* (in Number), 2005, 2008F & 2012F
Figure 5-2: US - Cancer Market (in Million US$) 1999, 2004, 2007E & 2012F
Figure 5-3: US - Cancer Market by Therapy Area (%) 1999, 2004, 2007E & 2012F
Figure 5-4: Europe - New Cancer Cases* (in Number), 2004, 2006 & 2012F
Figure 5-5: Europe - Cancer Market (in Billion US$), 2004, 2007E & 2012F
Figure 5-6: Japan - Cancer Market (in Billion US$), 2005, 2007E & 2012F
Figure 5-7: India - New & Total Number of Cancer Patients (in Million)
Figure 5-8: China - New & Total Number of Cancer Patients (in Million)
Figure 5-9: India - Cancer Market (in Million US$), 2007 & 2012F
Figure 6-1: Global - Cancer Drug Delivery Market (in Billion US$), 2005E, 2010F & 2015F
Figure 6-2: Global - Cancer Diagnostics Market (in Billion US$), 2002, 2007E & 2012F
Figure 6-3: Global* - Cancer Drugs going Off-patent (in Billion US$), 2008-2014
Figure 6-4: Global* - Cancer Generic Market (in Billion US$), 2004, 2005, 2007E & 2014F
Figure 6-5: Global* - Cancer Generic Market by Country (%), 2005
Figure 7-1: Success Rates of Drugs by Therapy Area from First in Man to Registration (%)
Table 6-1: Global - Cancer Diagnostics Market by Type of Test (in Million US$), 2002-2006E
Customers who bought this item also bought
The Cancer Market Outlook to 2012
Cancer Drug Discoveries: What the Future Holds: Prostate Cancer Chapter
Cancer Therapies - Global Strategic Business Report
Cancer Drug Resistance
US Cancer Pain Report
Cancer Drug Discoveries: What the Future Holds: Colorectal Cancer Chapter
Cancer Drug Discoveries: What the Future Holds
Drug Delivery in Cancer - Technologies, Markets and Companies
Trends in Cancer Treatment Drugs
China Anti-Cancer Drug Market Report 2008
Looking at the Cancer Therapy Market
Cancer Therapies - Global Market Opportunities
|
|
|
|
